Abeona Therapeutics (ABEO) News Today $5.66 +0.12 (+2.17%) Closing price 04:00 PM EasternExtended Trading$5.74 +0.08 (+1.41%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Abeona Therapeutics' (ABEO) "Hold (C-)" Rating Reiterated at Weiss RatingsOctober 8 at 1:20 PM | marketbeat.comAbeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene TherapyOctober 8 at 7:30 AM | globenewswire.comJoseph Walter Vazzano Sells 9,035 Shares of Abeona Therapeutics (NASDAQ:ABEO) StockOctober 2, 2025 | insidertrades.comAbeona Therapeutics (NASDAQ:ABEO) CFO Sells $48,698.65 in StockOctober 1, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) SVP Brendan O'malley Sells 9,366 SharesOctober 1, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 19,274 SharesOctober 1, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics (NASDAQ:ABEO) CEO Sells 25,000 Shares of StockOctober 1, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 1, 2025 | globenewswire.comGoldman Sachs Group Inc. Purchases 66,422 Shares of Abeona Therapeutics Inc. $ABEOSeptember 23, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Rating of "Buy" from AnalystsSeptember 21, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Shares Cross Below 50-Day Moving Average - What's Next?September 18, 2025 | marketbeat.comAbeona Therapeutics Inc. $ABEO Shares Acquired by Trexquant Investment LPSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 1,210,732 Shares of Abeona Therapeutics Inc. $ABEOSeptember 9, 2025 | marketbeat.comShould You Invest in Abeona Therapeutics (ABEO)?September 8, 2025 | insidermonkey.comAbeona Therapeutics Inc. $ABEO Shares Bought by Newtyn Management LLCSeptember 7, 2025 | marketbeat.comAbeona Therapeutics Inc. Stock (ABEO) Opinions on Upcoming Revenue InitiationSeptember 5, 2025 | quiverquant.comQ683 Capital Management LLC Has $3.21 Million Holdings in Abeona Therapeutics Inc. $ABEOSeptember 4, 2025 | marketbeat.comWellington Management Group LLP Purchases 59,832 Shares of Abeona Therapeutics Inc. $ABEOSeptember 3, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 2, 2025 | globenewswire.comWalleye Capital LLC Sells 402,944 Shares of Abeona Therapeutics Inc. $ABEOSeptember 2, 2025 | marketbeat.comAbeona Therapeutics® Announces Participation in Upcoming Investor ConferencesAugust 29, 2025 | globenewswire.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Given Consensus Rating of "Buy" by BrokeragesAugust 29, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Buy" by AnalystsAugust 29, 2025 | marketbeat.comQ3 EPS Estimate for Abeona Therapeutics Increased by AnalystAugust 23, 2025 | marketbeat.comHC Wainwright Issues Negative Estimate for ABEO EarningsAugust 22, 2025 | marketbeat.comQ1 EPS Estimate for Abeona Therapeutics Lowered by AnalystAugust 21, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2025 Earnings Call TranscriptAugust 20, 2025 | msn.comAbeona Therapeutics (NASDAQ:ABEO) Given "Buy" Rating at HC WainwrightAugust 20, 2025 | marketbeat.comAbeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comABEO: First Patient Treatment with Zevaskyn Expected in 3Q25…August 18, 2025 | finance.yahoo.comAbeona Therapeutics (NASDAQ:ABEO) Releases Earnings Results, Beats Expectations By $2.10 EPSAugust 17, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at OppenheimerAugust 17, 2025 | marketbeat.comAbeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond ZevaskynAugust 15, 2025 | seekingalpha.comAbeona Therapeutics Reports Strong Financial TurnaroundAugust 15, 2025 | msn.comAbeona Therapeutics price target raised to $20 from $19 at OppenheimerAugust 15, 2025 | msn.comAbeona Therapeutics expects cash to fund operations for over two yearsAugust 14, 2025 | msn.comAbeona Therapeutics reports Q2 EPS ($1.71) vs (26c) last yearAugust 14, 2025 | msn.comAbeona Therapeutics Shares Rise on Higher 2Q Net, Drug LaunchAugust 14, 2025 | marketwatch.comAbeona Therapeutics: Q2 Earnings SnapshotAugust 14, 2025 | chron.comAbeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 14, 2025 | globenewswire.comAAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses ...August 5, 2025 | finance.yahoo.comAbeona Therapeutics (ABEO) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Rating of "Buy" from BrokeragesAugust 3, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comAbeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene TherapyAugust 1, 2025 | msn.comHow A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’July 31, 2025 | forbes.comAscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease PatientsJuly 29, 2025 | globenewswire.comAbeona Therapeutics Inc News (ABEO) - Investing.comJuly 23, 2025 | investing.comAbeona Therapeutics Inc. (NASDAQ:ABEO) About To Shift From Loss To ProfitJuly 17, 2025 | finance.yahoo.comZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay AreaJuly 15, 2025 | tmcnet.com Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABEO Media Mentions By Week ABEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼0.730.77▲Average Medical News Sentiment ABEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼44▲ABEO Articles Average Week Get the Latest News and Ratings for ABEO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Pharming Group News Collegium Pharmaceutical News Immunome News Rapport Therapeutics News ARS Pharmaceuticals News Upstream Bio News Cronos Group News Nanobiotix News Valneva News Precigen News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
